Abivax Share Price

Abivax Share Price

NASDAQ: ABVX | Others
$83.61
+$1.51 (1.84%) Last updated on 19 Nov, 2026 | 01:27 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Abivax Stock Performance

Open
$82.96
Prev. Close
$82.09
Circuit Range
N/A
Day Range
$82.96 - $84.44
Year Range
$69.91 - $148.46
Volume
55,443
Average Traded
$83.76

Abivax Share Price Today

As of 19 November 2026, Abivax SA's share price is $83.61. The stock opened at $82.96, compared to its previous close of $82.09. During today's trading session, Abivax SA's share price traded between $82.96 and $84.44, with an average price of $83.70. Over the past 52 weeks, the stock has recorded a high of $148.46 and a low of $69.91. In terms of performance, Abivax SA's share price has declined by 37.08% over the last six months and is down 33.09% on a year-on-year basis.

Abivax Share Price Chart

Line chart of the Abivax price trend over the selected period. The price rose overall, ranging from 82.96 to 84.44, ending at 83.61.
$82.96$84.44
L
Show Current Price
H

Abivax Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$5.36B
Return On Equity (TTM)
N/A
Profit Margin
-7357.09%
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Abivax Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$5.11$12.95$5.36
Net Profit-$163.32-$183.39-$394.34
Net Profit Margin-3196.09%-1416.14%-7357.09%
Income ChangeN/A-12.29%-115.03%

Abivax Balance Sheet

All figures in USD Million

Particulars202520242023
Non Current Assets38.8335.9645.42
Current Assets646.76177.59316.13
Total Assets685.59213.55361.55
Non Current Liabilities77.5773.5144.61
Current Liabilities73.9497.81100.26
Total Liabilities151.51171.32144.87
Shareholders' Equity534.0842.23216.68

Abivax Cash Flow

Annually

All figures in USD Million

Particulars202520242023
Operating-189.05-160.32-107.37
Investing-9.6116.4-8.95
Financing642.1429.35370.65

About Abivax

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.

Abivax Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$87.17
$83.61
-3.49%
Oct 2026
$96.47
$86.63
-12.55%
Sep 2026
$112.36
$99.06
-13.40%
Aug 2026
$121.38
$114.39
-8.30%
Jul 2026
$137.75
$124.74
-6.41%
Jun 2026
$131.90
$133.28
+0.31%
May 2026
$117.50
$132.87
+13.25%
Apr 2026
$113.39
$117.32
+5.34%
Mar 2026
$117.66
$111.38
-8.18%
Feb 2026
$108.94
$121.30
+9.13%
Jan 2026
$136.56
$111.15
-17.62%
Dec 2025
$124.82
$134.92
+7.97%

Abivax Share Price FAQs